Gnant M, Steger G, Greil R, et al. A prospective randomized multi-center phase-III trial of additional 2 versus additional 5 years of anastrozole after initial 5 years of adjuvant endocrine therapy – results from 3,484 postmenopausal women in the ABCSG-16 trial. SABCS 2017, GS3-01.
Europese goedkeuring pembrolizumab bij NSCLC met tumor-PD-L1 expressie ≥ 50%
feb 2017 | Longoncologie